US 9156829
Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists
granted A61KA61K31/44A61K31/4439
Quick answer
US patent 9156829 (Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/44, A61K31/4439, A61K31/4965, A61K31/497